Vol 11, No 4 (August 13, 2021): Cardiovascular Diagnosis and Therapy

Original Article

Prognostic value of CT-derived myocardial blood flow, CT fractional flow reserve and high-risk plaque features for predicting major adverse cardiac events
Lihua Yu, Zhigang Lu, Xu Dai, Chengxing Shen, Lei Zhang, Jiayin Zhang
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:956-966
.
A single-center analysis of outcomes, risk factors, and new valves in Asian patients treated with early transcatheter aortic valve implantation
Ying Liang, Wei Wang, Xu Wang, Feilong Hei, Yulong Guan
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:967-979
.
Differences in socio-demographic and risk factor profile, clinical presentation, and outcomes between patients with and without RHD heart failure in Sub-Saharan Africa: results from the THESUS-HF registry
Clovis Nkoke, Albertino Damasceno, Christopher Edwards, Beth Davison, Gad Cotter, Mahmoud Sani, Lauren Gaeta, Okechukwu S. Ogah, Charles Mondo, Dike Ojji, Ahmed Suliman, Gerald Yonga, Serigne Abdou Ba, Anastase Dzudie, Karen Sliwa
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:980-990
.
Non-fasting lipid profile for cardiovascular risk assessments using China ASCVD risk estimator and Europe SCORE risk charts in Chinese participants
Shi-Lan Zhang, Xiao Du, Jin Xu, Qun-Yan Xiang, Ling Liu
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:991-1001
.
Long term mortality and readmissions after transcatheter aortic valve replacement
Mourad H. Senussi, John Schindler, Ibrahim Sultan, Ahmad Masri, Forozan Navid, Dustin Kliner, Arman Kilic, Michael S. Sharbaugh, Amr Barakat, Andrew D. Althouse, Joon S. Lee, Thomas G. Gleason, Suresh R. Mulukutla
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1002-1012
.

Case Report

Checkpoint inhibitor-induced fulminant myocarditis, complete atrioventricular block and myasthenia gravis—a case report
Antonio Portolés Hernández, Mariola Blanco Clemente, Daniel Escribano García, Rocío Velasco Calvo, Beatriz Núñez García, Juan Francisco Oteo Domínguez, Clara Salas Antón, Miriam Méndez García, Javier Segovia Cubero, Fernando Domínguez
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1013-1019
.

Letter to the Editor

Optimal bridge to recovery strategy for children
Teruhiko Imamura
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1020-1021
.

News

Application of the CARE guideline as reporting standard in the Cardiovascular Diagnosis and Therapy
Editorial Office
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1022
.

Editorial on Pediatric Pulmonary Hypertension1

Pediatric pulmonary hypertension
Christian Apitz, Astrid E. Lammers
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1023-1027
.

Original Article on Pediatric Pulmonary Hypertension1

Effects of exercise training on heart rate variability in children and adolescents with pulmonary arterial hypertension: a pilot study
Jannos Siaplaouras, Marc Frerix, Anita Apitz, David Zöller, Christian Apitz
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1028-1036
.
Hemodynamic and prognostic impact of the diastolic pulmonary arterial pressure in children with pulmonary arterial hypertension—a registry-based analysis
Christian Apitz, Rolf M. F. Berger, D. Dunbar Ivy, Tilman Humpl, Damien Bonnet, Maurice Beghetti, Dietmar Schranz, Heiner Latus; on behalf of the TOPP investigators
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1037-1047
.

Brief Report on Pediatric Pulmonary Hypertension1

Update from the World Symposium on Pulmonary Hypertension 2018: does the new hemodynamic definition of pediatric pulmonary hypertension have an impact on treatment strategies?
Astrid E. Lammers, Christian Apitz
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1048-1051
.

Case Report on Pediatric Pulmonary Hypertension1

Moyamoya disease associated with pediatric pulmonary hypertension—a case report
Johannes Krämer, Meinrad Beer, Michael Kaestner, Peter Bride, Benedikt Winter, Christian Apitz
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1052-1056
.

Review Article on Pediatric Pulmonary Hypertension1

Role of cardiovascular magnetic resonance in pediatric pulmonary hypertension—novel concepts and imaging biomarkers
Heiner Latus, Christian Meierhofer
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1057-1069
.
Pulmonary veno-occlusive disease in childhood—a rare disease not to be missed
Marc Pfluger, Tilman Humpl
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1070-1079
.
Heart failure therapy based on interventricular mechanics and cardio-vascular communications
Dietmar Schranz, Hakan Akintuerk, Anoosh Esmaeili, Heiner Latus, Christian Apitz
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1080-1088
.
Prognostic biomarkers in pediatric pulmonary arterial hypertension
Mark-Jan Ploegstra, Rolf M. F. Berger
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1089-1101
.
Cardiac catheterization in pediatric pulmonary hypertension: a systematic and practical approach
Michael Kaestner, Christian Apitz, Astrid Elisabeth Lammers
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1102-1110
.
Pulmonary vascular disease in Fontan circulation—is there a rationale for pulmonary vasodilator therapies?
Kolja Becker, Anselm Uebing, Jan Hinnerk Hansen
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1111-1121
.
Altitude exposure in pediatric pulmonary hypertension—are we ready for (flight) recommendations?
Ulrike Herberg, Ralf Knies, Nicole Müller, Johannes Breuer
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1122-1136
.
Systemic sclerosis-associated pulmonary arterial hypertension in children
Christian Apitz, Hermann Girschick
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1137-1143
.
Treatment of pulmonary arterial hypertension in children
Matthias Gorenflo, Victoria C. Ziesenitz
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1144-1159
.
A guide to echocardiographic assessment in children and adolescents with pulmonary hypertension
Astrid E. Lammers, Christian Apitz, Ina Michel-Behnke, Martin Koestenberger
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1160-1177
.
Lung transplantation for pediatric pulmonary arterial hypertension—quo vadis?
Wiebke Sommer, Gregor Warnecke
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1178-1189
.
Treatment of adults with Eisenmenger syndrome—state of the art in the 21st century: a short overview
Gerhard-Paul Diller, Astrid E. Lammers, Erwin Oechslin
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1190-1199
.

Arts and Medicine2

Artworks from Valeriya N-Georg: exploring the body and soul
Valeriya N-Georg
Cardiovascular Diagnosis and Therapy  
2021;
11
(4)
:1200-1204
.

Disclosure:

1. The series “Pediatric Pulmonary Hypertension” was commissioned by the editorial office, Cardiovascular Diagnosis and Therapy without any sponsorship or funding. Christian Apitz and Astrid Lammers served as the unpaid Guest Editors for the series.

2. The series “Arts and Medicine” was commissioned by the editorial office, Cardiovascular Diagnosis and Therapy without any sponsorship or funding.